AbCellera Biologics Inc. (ABCL)
NASDAQ·Healthcare·Biotechnology
$5.37
+1.61%
Mkt Cap $1.75B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$7.50
Range $7.00 – $8.00
Implied Upside
+39.7%
Consensus $7.50 vs current $5.37
NASDAQ·Healthcare·Biotechnology
$5.37
+1.61%
Mkt Cap $1.75B
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$7.50
Range $7.00 – $8.00
+39.7%
Consensus $7.50 vs current $5.37